99 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
of those arrangements do not encourage unnecessary risk-taking;
overseeing any major changes in employee benefits structures throughout the company … after such change in control.
-37-
Pension, Retirement or Similar Benefits
Mereo operates a defined contribution pension scheme which is available
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
on the overall development and regulatory strategies. The benefits of a PRIME designation includes the appointment of a dedicated contact and rapporteur from … the standards for the evaluation of benefits and risks or the requirement to demonstrate a positive benefit-risk balance to obtain MA. In February 2017
10-K
2023 FY
EX-19.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
then trades on the basis of the information. Penalties may apply regardless of whether the tipper derives any benefits from the tippee’s trading
10-K
2023 FY
EX-97.1
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
, and provide such opinion to Nasdaq; or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly
8-K
EX-99.1
MREO
Mereo Biopharma Group Plc
8 Jan 24
Mereo BioPharma Provides Update on Pipeline Progress and Corporate Developments
7:08am
in the proposed Phase 3 study based on benefits observed in patients with the severe Pi*ZZ phenotype, including those who are in the early stages
6-K
EX-3.1
ykyf0v6vac9qzpwio j8
18 Dec 23
Current report (foreign)
4:10pm
6-K
EX-99.2
ql97fa4
7 Sep 23
Current report (foreign)
7:37am
6-K
EX-99.2
3o8tmtpkgmmkiiejuh
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.1
wx548jm
2 Nov 22
Current report (foreign)
4:17pm
6-K
EX-99.2
p8qtli
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
CORRESP
sz8j0c 26o7l2l
19 Aug 22
Correspondence with SEC
12:00am
6-K
EX-3.1
5vu husbupd8motm1
17 May 22
Current report (foreign)
8:26am